Open AccessTriglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects
Author(s) -
Shujun Zhang,
Tingting Du,
Mengni Li,
Junjing Jia,
Hongyan Lü,
Xuan Lin,
Xuefeng Yu
Publication year - 2017
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000007041
Subject(s) - medicine , nonalcoholic fatty liver disease , body mass index , odds ratio , quartile , fatty liver , confidence interval , gastroenterology , insulin resistance , population , triglyceride , obesity , overweight , confounding , endocrinology , disease , cholesterol , environmental health
Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is highly correlated with obesity; however, it is not uncommon among nonobese individuals. Triglyceride (TG) and glucose index combined with body mass index (TyG-BMI) has been proposed as a favorable marker of insulin resistance. We sought to investigate the effectiveness of TyG-BMI in identifying NAFLD in nonobese subjects. We conducted a cross-sectional study in a nonobese (BMI <25.0 kg/m 2 ) Chinese population (N = 6809) of adults who underwent health examinations, including abdominal ultrasonography. The prevalence of ultrasonography-detected NAFLD was 23.9% in nonobese subjects. After adjusting for potential confounders, every 1-standard deviation increase in TyG-BMI had an odds ratio (OR) of 3.4 [95% confidence interval (95% CI), 3.0–3.9] for NAFLD. Compared with the lowest quartile of TyG-BMI, multivariable-adjusted ORs were 2.4 (1.6–3.6), 6.4 (4.2–9.7), and 15.3 (9.8–23.9) for those in the second, third, and fourth quartile, respectively. According to the receiver operating characteristic curve analysis, TyG-BMI was effective in diagnosing patients with NAFLD with an area under the curve of 0.835 (95% CI, 0.824–0.845). In comparison, TyG-BMI was superior to its components, including TyG, BMI, TG, and fasting plasma glucose, for identifying nonobese subjects at risk for NAFLD. In this study, the prevalence of NAFLD was over one-fifth in the nonobese population. TyG-BMI was an effective marker to detect NAFLD in nonobese subjects.